Calcium Channel Blockers Potentiate Gemcitabine Chemotherapy in Pancreatic Cancer

By
Ishira
-
0
263
Researchers identified novel strategies to prevent, delay, or overcome resistance to gemcitabine, one of the most widely used medications in PDAC.
[Proceedings of the National Academy of Sciences of the United States of America]
Abstract